Depression Consultant
Better treatment through informed communication

Main Menu

  • Home
    • Depressing Medical Mistakes
    • Clinical Wisdom Versus Evidence-Based Treatment
    • Taking the Measure of Depression
    • Bad Messages About Good Treatments
    • Improving the Diagnosis of Depression
    • Trapped at the End of the Second Act
    • Adverse Responders and Antidepressant Effectiveness
    • The Antidepressant Debate
    • Review on Antidepressants and Comment published by New York Times
    • Empowering the Depressed Patient
    • Misinformation about Antidepressants on the Internet
    • What About Bipolar Disorder?
    • The Unfriending of Serotonin
    • What "60 Minutes" Didn't Say About Antidepressants
    • How to Personalize the Treatment of Depression
    • Neuroplastic Man Untangled
    • Throwing Away the PITS
    • A Few of Our Current Patients
    • Researcher-Clinician Synergy
    • A Welcome to Health Professionals
    • A Welcome to Non-Health Professionals
  • Research for Professionals
    • Metzner, 2000 APA Annual Meeting Presentation
    • Metzner, 2005 APA Annual Meeting Presentation
    • Metzner RJ and Ho AP - APA 2007 New Research
    • Metzner & Ho, 2009 APA Annual Meeting Presentation
    • Can clinicians improve antidepressant remission rates with better treatment algorithms?
    • A Symptom-Guided System for Improving Antidepressant Outcomes: An Observational Study
      • A Symptom-Guided System for Improving Antidepressant Outcomes: An Observational Study-html with links
        • Why hasn't this report been published in a journal?
        • BMC Medicine reply
        • Peer Review
  • Contact
  1. You are here:  
  2. Home
  3. General

Review on Antidepressants and Comment published by New York Times

 If you would like to read a good review on antidepressants, I recommend "Post-Prozac Nation: The Science and History of Treating Depression" by Siddhartha Mukherjee, M.D., which appeared in the New York Times Magazine online on April 19, 2012.

 

Richard J. Metzner, M.D.

Clinical Professor

Semel Institute for Neuroscience and Human Behavior at UCLA

Founder, DepressionConsultant.com

 

I have just one issue with it, which I expressed in the following posted comment.

 

 

--------------------

The above link to this website brought us hundreds of visitors. We appreciate all of you and hope you will give us your feedback at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

 

Copyright 2012, Scaled Psychiatric Systems, Inc. All rights reserved.

For Patients and Professionals (select image below to view full screen)

A Message for Non-Health Professionals.

    Latest News 

                      

Choosing an antidepressant
doesn't have to be a guessing game. 

 

 

For Everyone Interested in Improving the Treatment of Depression x

Health Professionals

Non-Health Professionals

 

App store screen

                      

Choosing an antidepressant
doesn't have to be a guessing game. 

 

 

What "60 Minutes" Didn’t Say About Antidepressants

The inability of antidepressants to prove more effective than placebos in many clinical trials has been discussed widely during the past few years, but CBS's "60 Minutes" gave the topic new life with an "explosive" segment on February 19, 2012. What they failed to acknowledge to the detriment of millions of depressed people was that experienced clinicians get much better results in practice.

 

Richard J. Metzner, M.D.

Clinical Professor

Semel Institute for Neuroscience and Human Behavior at UCLA

Founder, DepressionConsultant.com

  

In a multi-site study we have been undertaking, we have seen clinicians using the algorithm of the Clinaptica Depression Consultant app obtain remission rates as high as 59% or better -- about twice what placebos usually get. (Can Clinicians Improve Antidepressant Remission Rates with Better Algorithms? Metzner RJ and Ho AL, 2009)

Read more: What "60 Minutes" Didn’t Say About Antidepressants